Since March, over 400 US colleges and universities have announced students get Covid-19 vaccinations, ahead of the Autumn semester but those who have been inoculated with India’s indigenous Covaxin or the Russian-made Sputnik V are being asked to re-vaccinate as these vaccines have not yet been approved by the World Health Organization (WHO).
Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India.
Delhi is likely to receive the first consignment of Sputnik V, the Russian COVID-19 vaccine, in June, Delhi Chief Minister Arvind Kejriwal said on Monday, while stressing that vaccination is key to the fight against coronavirus.
Congress leader Rahul Gandhi on Wednesday took a jibe at the central government after it granted permission for emergency use authorisation of Sputnik-V, the Russian vaccine against COVID-19.
India has become the 60th country to authorize the use of the Russian Sputnik V vaccine against coronavirus, and the vaccine is now approved in countries with a total population of 3 billion, or 40 percent of the world’s population, the Russian Direct Investment Fund (RDIF) said on Monday.
Dr Reddy’s Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from phase two clinical trial of Russia’s Covid-19 vaccine Sputnik V and recommended phase three recruitment along with continuing clinical trial without any modifications.
India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said.
The Russian Sovereign Wealth Fund and India’s pharmaceutical company Hetero have agreed to produce over 100 million doses per year of the Russian COVID-19 vaccine Sputnik V in India, according to a statement on Sputnik V Twitter account on Friday.
English
English
English
